Peripheral Blood Lymphocyte Subgroups in Patients Undergoing Hemodialysis with Medium Cutoff Membranes and High-Flux
Nuri Baris Hasbal1, Mustafa Sevinc2, Vuslat Yilmaz3
1Division of Nephrology, Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.
Insights
Medium cutoff (MCO) membranes, used in dialysis for end-stage kidney disease (ESKD), promote an anti-inflammatory immune response. MCO membranes favorably modulated lymphocyte subpopulations, suggesting improved patient outcomes.
Area of Science:
- Nephrology
- Immunology
- Biomedical Engineering
Background:
- Chronic kidney disease (CKD) is a growing global health concern with high mortality rates.
- Inflammation is a key factor in CKD pathogenesis, but its mechanisms are not fully understood.
- Medium cutoff (MCO) membranes offer potential benefits in hemodialysis by clearing toxins while minimizing albumin loss.
Purpose of the Study:
- To investigate the effects of MCO versus high-flux (HF) membranes on peripheral blood lymphocyte subpopulations in hemodialysis patients.
- To assess the immunomodulatory impact of different dialysis membrane types.
Main Methods:
- Twenty-four end-stage kidney disease (ESKD) patients participated in the study.
- Each patient underwent 36 hemodialysis sessions, alternating between MCO and HF membranes.
- Lymphocyte subsets were analyzed using immunophenotyping via flow cytometry.
Main Results:
- MCO membranes led to a significant increase in Natural Killer (NK) cells.
- T helper 2 (Th2) and T follicular helper (Tfh) cells increased with MCO, while Th1 cells decreased post-HF.
- Regulatory T (Treg) cells remained stable with MCO but decreased with HF dialysis.
Conclusions:
- MCO dialysis demonstrated an anti-inflammatory effect, indicated by increased Th2/Tfh cells and stable Treg cells.
- MCO membranes positively influenced NK cell populations.
- These findings suggest MCO membranes have the potential to modulate immune responses and improve outcomes in ESKD patients.
Introduction:
Chronic kidney disease (CKD) poses a significant global health burden, with increasing prevalence and high morbidity and mortality rates, particularly in end-stage kidney disease (ESKD). While traditional risk factors contribute, the exact mechanisms remain elusive, with inflammation playing a pivotal role. Medium cutoff (MCO) membranes offer promise in improving dialysis outcomes by efficiently clearing uremic toxins without substantial albumin loss. We aimed to elucidate the impact of MCO and high-flux (HF) membranes on peripheral blood lymphocyte subpopulations in hemodialysis patients.
Methods:
Twenty-four ESKD patients underwent 36 sessions each with MCO and HF membranes. Immunophenotyping by flow cytometry was performed to analyze lymphocyte subsets.
Results:
NK cell percentages significantly increased with MCO, returning to baseline with HF. Th1 cells decreased post-HF, while Th2 and Tfh cells increased with MCO and persisted. Treg cells remained stable with MCO but decreased with HF.
Conclusion:
MCO dialysis induced an anti-inflammatory shift, evidenced by increased Th2 and Tfh cells and stable Treg cells. NK cells also responded favorably to MCO. These findings underscore MCO membranes' potential to modulate immune responses and improve patient outcomes in ESKD.
More Related Videos
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
